Michael K. Riscoe

5.7k total citations · 1 hit paper
83 papers, 3.4k citations indexed

About

Michael K. Riscoe is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Parasitology. According to data from OpenAlex, Michael K. Riscoe has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Public Health, Environmental and Occupational Health, 36 papers in Molecular Biology and 18 papers in Parasitology. Recurrent topics in Michael K. Riscoe's work include Malaria Research and Control (32 papers), Biochemical and Molecular Research (20 papers) and HIV/AIDS drug development and treatment (14 papers). Michael K. Riscoe is often cited by papers focused on Malaria Research and Control (32 papers), Biochemical and Molecular Research (20 papers) and HIV/AIDS drug development and treatment (14 papers). Michael K. Riscoe collaborates with scholars based in United States, Canada and Switzerland. Michael K. Riscoe's co-authors include Jane X. Kelly, Martin J. Smilkstein, Rolf W. Winter, Prapon Wilairat, Nongluk Sriwilaijaroen, David J. Hinrichs, Ken Cornell, Rozalia A. Dodean, Marina Ignatushchenko and Aaron Nilsen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael K. Riscoe

81 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening

2004 915 citations Martin J. Smilkstein, Jane X. Kelly et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael K. Riscoe United States	31	1.4k	1.4k	666	533	495	83	3.4k
Prapon Wilairat Thailand	34	1.6k 1.1×	1.4k 1.1×	1.2k 1.8×	374 0.7×	250 0.5×	132	4.5k
Norman C. Waters United States	33	1.5k 1.0×	902 0.7×	457 0.7×	339 0.6×	239 0.5×	84	2.8k
Elisabeth Davioud–Charvet France	35	1.1k 0.8×	1.3k 1.0×	1.4k 2.1×	510 1.0×	355 0.7×	102	3.5k
Sumalee Kamchonwongpaisan Thailand	33	2.3k 1.6×	1.5k 1.1×	917 1.4×	535 1.0×	239 0.5×	122	4.5k
Françoise Benoit‐Vical France	36	2.8k 1.9×	1.0k 0.8×	742 1.1×	421 0.8×	426 0.9×	115	4.7k
Tina S. Skinner‐Adams Australia	34	1.5k 1.1×	1.2k 0.9×	467 0.7×	662 1.2×	511 1.0×	88	3.2k
Sylke Müller United Kingdom	42	1.6k 1.1×	2.2k 1.6×	307 0.5×	577 1.1×	599 1.2×	77	3.8k
Heinrich C. Hoppe South Africa	30	925 0.6×	891 0.7×	616 0.9×	498 0.9×	384 0.8×	132	2.9k
Sergio Wittlin Switzerland	35	2.3k 1.6×	1.1k 0.8×	1.4k 2.1×	420 0.8×	334 0.7×	138	4.2k
Kevin J. Saliba Australia	32	2.1k 1.5×	1.2k 0.9×	302 0.5×	371 0.7×	387 0.8×	77	3.6k

Countries citing papers authored by Michael K. Riscoe

Since Specialization

Citations

This map shows the geographic impact of Michael K. Riscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Riscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Riscoe more than expected).

Fields of papers citing papers by Michael K. Riscoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Riscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Riscoe. The network helps show where Michael K. Riscoe may publish in the future.

Co-authorship network of co-authors of Michael K. Riscoe

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Riscoe. A scholar is included among the top collaborators of Michael K. Riscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Riscoe. Michael K. Riscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cardillo, Natalia M., Nicolás F. Villarino, Michael K. Riscoe, et al.. (2024). The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against Babesia bovis In Vitro. Pharmaceutics. 16(11). 1402–1402. 1 indexed citations

Yamaryo‐Botté, Yoshiki, Michel Nguyen, Marlène Marcellin, et al.. (2024). In artemisinin-resistant falciparum malaria parasites, mitochondrial metabolic pathways are essential for survival but not those of apicoplast. International Journal for Parasitology Drugs and Drug Resistance. 26. 100565–100565. 1 indexed citations

Li, Yuexin, et al.. (2022). 2-Hydroxy-1,4-Naphthoquinones With 3-Alkyldiarylether Groups: Synthesis and Plasmodium Falciparum Inhibitory Activity. Future Medicinal Chemistry. 14(22). 1611–1620. 1 indexed citations

Renard, Isaline, Sovitj Pou, Rolf W. Winter, et al.. (2022). Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo. The Journal of Infectious Diseases. 226(7). 1267–1275. 18 indexed citations

Painter, Heather J., Joanne M. Morrisey, Michael W. Mather, et al.. (2021). Atypical Molecular Basis for Drug Resistance to Mitochondrial Function Inhibitors in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 65(3). 6 indexed citations

Renard, Isaline, Jose Thekkiniath, Sovitj Pou, et al.. (2021). Effective Therapy Targeting Cytochrome bc ₁ Prevents Babesia Erythrocytic Development and Protects from Lethal Infection. Antimicrobial Agents and Chemotherapy. 65(9). e0066221–e0066221. 21 indexed citations

Renard, Isaline, Santosh George, Sukanya Narasimhan, et al.. (2021). Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle. The Journal of Infectious Diseases. 225(1). 135–145. 10 indexed citations

Doggett, J. Stone, Tracey L. Schultz, Alyssa J. Miller, et al.. (2020). Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts. Antimicrobial Agents and Chemotherapy. 64(9). 22 indexed citations

Mather, Michael W., et al.. (2020). Genetic ablation of the mitoribosome in the malaria parasite Plasmodium falciparum sensitizes it to antimalarials that target mitochondrial functions. Journal of Biological Chemistry. 295(21). 7235–7248. 22 indexed citations

10.

Silva, Marta G., Reginaldo G. Bastos, J. Stone Doggett, et al.. (2020). Endochin-like quinolone-300 and ELQ-316 inhibit Babesia bovis, B. bigemina, B. caballi and Theileria equi. Parasites & Vectors. 13(1). 606–606. 13 indexed citations

11.

Smilkstein, Martin J., Sovitj Pou, Rozalia A. Dodean, et al.. (2019). ELQ-331 as a prototype for extremely durable chemoprotection against malaria. Malaria Journal. 18(1). 291–291. 13 indexed citations

12.

Janowsky, Aaron, Amy J. Eshleman, Robert A. Johnson, et al.. (2014). Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro. Psychopharmacology. 231(14). 2771–2783. 28 indexed citations

13.

Kelly, Jane X., Martin J. Smilkstein, Reto Brun, et al.. (2009). Discovery of dual function acridones as a new antimalarial chemotype. Nature. 459(7244). 270–273. 143 indexed citations

14.

Flythe, Jennifer E., Jose Rueda, Michael K. Riscoe, & Suzanne Watnick. (2008). Silicate Nephrolithiasis After Ingestion of Supplements Containing Silica Dioxide. American Journal of Kidney Diseases. 54(1). 127–130. 9 indexed citations

15.

Dodean, Rozalia A., Jane X. Kelly, David H. Peyton, et al.. (2007). Synthesis and heme-binding correlation with antimalarial activity of 3,6-bis-(ω-N,N-diethylaminoamyloxy)-4,5-difluoroxanthone. Bioorganic & Medicinal Chemistry. 16(3). 1174–1183. 17 indexed citations

16.

Burgess, Steven, et al.. (2006). A Chloroquine-like Molecule Designed to Reverse Resistance in Plasmodium falciparum. Journal of Medicinal Chemistry. 49(18). 5623–5625. 118 indexed citations

17.

Riscoe, Michael K., Jane X. Kelly, & Rolf W. Winter. (2005). Xanthones as Antimalarial Agents: Discovery, Mode of Action, and Optimization. Current Medicinal Chemistry. 12(21). 2539–2549. 82 indexed citations

18.

Marracci, Gail, et al.. (2004). α lipoic acid inhibits human T‐cell migration: Implications for multiple sclerosis. Journal of Neuroscience Research. 78(3). 362–370. 43 indexed citations

19.

Yip, Patrick, et al.. (2003). Crystallization and preliminary X-ray analysis of 5′-methylthioribose kinase fromBacillus subtilisandArabidopsis thaliana. Acta Crystallographica Section D Biological Crystallography. 60(1). 116–119. 9 indexed citations

20.

Cornell, Ken & Michael K. Riscoe. (1998). Cloning and expression of Escherichia coli 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase: Identification of the pfs gene product. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1396(1). 8–14. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact